A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
Clinical trial NCT03987451 · COMPLETED
Trial details
- NCT number
- NCT03987451
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-18
- Primary completion
- 2021-04-22
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.